A high-throughput approach measures cell type-specific telomere lengths in fixed archival tissues from patient cohorts for research on prognosis

Telomeres, the repetitive DNA elements at chromosome ends, are pivotal for maintenance of genome integrity. Previous studies from our group and others have highlighted the translational potential of tissue-based telomere length measurements to address the clinical challenge of improving diagnosis, individualized risk stratification, and accurate prognostication of different diseases. Here, we describe a high-throughput method that quantitates cell type-specific telomere lengths at a single cell level in archival tissues from patient cohorts for research on prognosis. This approach is based on telomere-specific fluorescence in situ hybridization (FISH) combined with multiplex immunostaining for cell type-specific antibodies, followed by semi-automated slide scanning and multi-channel acquisition of fluorescent images using the TissueFAXS Plus microscopy workstation and TissueQuest software (TissueGnostics). Here, we demonstrate that this method is sufficiently robust and reproducible to detect biologically significant differences in telomere lengths in archived tissues either on whole slides or sampled across tissue microarrays, which is essential when assessing prognosis in large patient cohorts.

[1]  Tsung-Po Lai,et al.  Comparison of telomere length measurement methods , 2018, Philosophical Transactions of the Royal Society B: Biological Sciences.

[2]  G. Danuser,et al.  A method for measuring the distribution of the shortest telomeres in cells and tissues , 2017, Nature Communications.

[3]  A. Meeker,et al.  Telomeres and telomerase in prostate cancer development and therapy , 2017, Nature Reviews Urology.

[4]  Karl Rohr,et al.  Quantification of telomere features in tumor tissue sections by an automated 3D imaging-based workflow. , 2017, Methods.

[5]  J. Shay,et al.  Telomere Restriction Fragment (TRF) Analysis. , 2015, Bio-protocol.

[6]  I. Thompson,et al.  Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial , 2015, The Prostate.

[7]  Anthony J. Cesare,et al.  Visualization of Telomere Integrity and Function In Vitro and In Vivo Using Immunofluorescence Techniques , 2015, Current Protocols in Cytometry.

[8]  Richard Durbin,et al.  Estimating telomere length from whole genome sequence data , 2014, Nucleic acids research.

[9]  Stacey A. Kenfield,et al.  Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death. , 2013, Cancer discovery.

[10]  Leslie A. Leinwand,et al.  The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity , 2012, Nature.

[11]  C. Harley,et al.  Measurement of telomere length by the Southern blot analysis of terminal restriction fragment lengths , 2010, Nature Protocols.

[12]  Richard M. Cawthon,et al.  Telomere length measurement by a novel monochrome multiplex quantitative PCR method , 2009, Nucleic acids research.

[13]  C. Heaphy,et al.  Telomeres: Prognostic markers for solid tumors , 2006, International journal of cancer.

[14]  D. Wynford‐Thomas,et al.  Extensive allelic variation and ultrashort telomeres in senescent human cells , 2003, Nature Genetics.

[15]  R. DePinho,et al.  Connecting chromosomes, crisis, and cancer. , 2002, Science.

[16]  R. Cawthon.  Telomere measurement by quantitative PCR. , 2002, Nucleic acids research.

[17]  W. Gage,et al.  Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining. , 2002, The American journal of pathology.

[18]  H. Vaziri.  Critical telomere shortening regulated by the ataxia-telangiectasia gene acts as a DNA damage signal leading to activation of p53 protein and limited life-span of human diploid fibroblasts. A review. , 1997, Biochemistry. Biokhimiia.

[19]  L. S. Cram,et al.  A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[20]  T. de Lange.  Telomere-related genome instability in cancer. , 2005, Cold Spring Harbor symposia on quantitative biology.